Mymetics Corporation

Mymetics Corporation

Mymetics Corporation is a biotechnology research and development company focused on fundamental and applied research in the area of human biology and medicine. Mymetics's primary objective is to develop vaccines and therapies to prevent and treat the effects of certain retroviruses and other infectious diseases, including the human immunodeficiency virus (HIV), the virus that leads to acquired immunodeficiency syndrome (AIDS). Mymetics has also acquired from a scientific partner an advanced malaria vaccine project, which is in phase II clinical trial. Additional applications of Mymetics's research include potential treatments and/or vaccines for malaria, human oncoviral leukemias, multiple sclerosis and organ transplantation. In April 2009, the Company completed the acquisition of Bestewil Holding B.V. and its subsidiary, Virosome Biologicals B.V., from Norwood Immunology Limited.

Contact Details

Office Address

Mymetics Corporation
Route de la Corniche 4, Epalinges, Switzerland 1066
Phone: +41-21-653-45-35
Fax: +41-21-653-24-73

Executives

Chairman, President, and CEO

Jacques-François Martin

CFO, Secretary, Treasurer, and Director

Ernst Luebke

Business Reviews for Mymetics Corporation

Related Companies